Aprea Therapeutics logo

Aprea Therapeutics Share Price Today

(NASDAQ: APRE)

Aprea Therapeutics share price is $2.64 & ₹229.60 as on 6 Mar 2025, 2.30 'hrs' IST

$2.64

0.09

(3.53%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Aprea Therapeutics share price in Dollar and Rupees. Guide to invest in Aprea Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Aprea Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Aprea Therapeutics share price movements

  • Today's Low: $2.51
    Today's High: $2.79

    Day's Volatility :10.04%

  • 52 Weeks Low: $2.15
    52 Weeks High: $8.40

    52 Weeks Volatility :74.4%

Aprea Therapeutics (APRE) Returns

PeriodAprea Therapeutics IncIndex (Russel 2000)
3 Months
-19.3%
0.0%
6 Months
-24.02%
0.0%
1 Year
-69.24%
0.0%
3 Years
-92.23%
-11.6%

Aprea Therapeutics (APRE) Key Statistics

in dollars & INR

Previous Close
$2.55
Open
$2.54
Today's High
$2.79
Today's Low
$2.51
Market Capitalization
$12.6M
Today's Volume
$30.2K
52 Week High
$8.4
52 Week Low
$2.1501
Revenue TTM
$1.3M
EBITDA
$-14.7M
Earnings Per Share (EPS)
$-2.8
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-60.22%

How to invest in Aprea Therapeutics Stock (APRE) from India?

It is very easy for Indian residents to invest directly in Aprea Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aprea Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Aprea Therapeutics or APRE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aprea Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aprea Therapeutics shares which would translate to 0.329 fractional shares of Aprea Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Aprea Therapeutics, in just a few clicks!

Returns in Aprea Therapeutics (APRE) for Indian investors in Rupees

The Aprea Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Aprea Therapeutics investment value today

Current value as on today

₹36,808

Returns

₹63,192

(-63.19%)

Returns from Aprea Therapeutics Stock

₹68,154 (-68.15%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Aprea Therapeutics (APRE)

-79%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Aprea Therapeutics Stock from India on INDmoney has decreased by -79% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Aprea Therapeutics

  • AIGH Capital Management, LLC

    9.92%

  • Sio Capital Management, LLC

    5.09%

  • Sphera Funds Management Ltd.

    4.97%

  • Nantahala Capital Management, LLC

    3.79%

  • Vanguard Group Inc

    3.20%

  • Stonepine Capital Management Llc

    2.75%

Analyst Recommendation on Aprea Therapeutics

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Aprea Therapeutics(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Aprea Therapeutics Stock (APRE)

What analysts predicted

Upside of 493.44%

Target:

$15.67

Current:

$2.64

Insights on Aprea Therapeutics Stock (Ticker Symbol: APRE)

  • Price Movement

    In the last 1 month, APRE stock has moved down by -37.1%
  • APRE vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 131.1%
  • APRE vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 139.7%
  • Price to Sales

    ForAPRE every $1 of sales, investors are willing to pay $9.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Aprea Therapeutics Technicals Summary

Sell

Neutral

Buy

Aprea Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Aprea Therapeutics (APRE) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Aprea Therapeutics Inc logo
-33.35%
-24.02%
-69.24%
-92.23%
-99.61%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Aprea Therapeutics Inc logo
0.48
NA
NA
-2.39
-0.6
-0.35
NA
4.04
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Aprea Therapeutics Inc logo
Buy
$12.6M
-99.61%
0.48
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Aprea Therapeutics

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidate is the ATRN-119 that is in Phase I clinical trials for treating advanced solid tumors. The company is also developing ATRN-1051 for the treatment of ovarian cancer; and APRE-DDRi for the treatment of advanced solid tumors. The company is headquartered in Doylestown, Pennsylvania.
Organization
Aprea Therapeutics
Employees
7
CEO
Dr. Oren Gilad Ph.D.
Industry
Commercial Services

Management People of Aprea Therapeutics

NameTitle
Dr. Oren Gilad Ph.D.
Co-Founder, CEO, President & Director
Mr. John P. Hamill CPA
Senior VP, CFO, Principal Accounting Officer & Secretary
Dr. Lars B. Abrahmsen Ph.D.
Senior VP & Chief Scientific Officer
Mr. Brian Wiley
Senior Vice President of Corporate Development & Strategy
Dr. Michel Afargan Ph.D.
Head of Pharmacology Development
Mr. Ze'ev Weiss B.Sc., C.P.A.
Chief Business Advisor
Ms. Andrea Epstein
Controller

Important FAQs about investing in APRE Stock from India :

What is Aprea Therapeutics share price today?

Aprea Therapeutics share price today stands at $2.64, Open: $2.54 ; Previous Close: $2.55 ; High: $2.79 ; Low: $2.51 ; 52 Week High: $8.40 ; 52 Week Low: $2.15.

The stock opens at $2.54, after a previous close of $2.55. The stock reached a daily high of $2.79 and a low of $2.51, with a 52-week high of $8.40 and a 52-week low of $2.15.

Can Indians buy Aprea Therapeutics shares?

Yes, Indians can invest in the Aprea Therapeutics (APRE) from India.

With INDmoney, you can buy Aprea Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Aprea Therapeutics at zero transaction cost.

How can I buy Aprea Therapeutics shares from India?

It is very easy to buy Aprea Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aprea Therapeutics (APRE) be purchased?

Yes, you can buy fractional shares of Aprea Therapeutics with INDmoney app.

What are the documents required to start investing in Aprea Therapeutics stocks?

To start investing in Aprea Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Aprea Therapeutics Stock (APRE)?

Today’s highest price of Aprea Therapeutics (APRE) is $2.79.

Today’s lowest price of Aprea Therapeutics (APRE) is $2.51.

What is today's market capitalisation of Aprea Therapeutics?

Today's market capitalisation of Aprea Therapeutics APRE is 12.6M

What is the 52 Week High and Low Range of Aprea Therapeutics Stock (APRE)?

  • 52 Week High

    $8.40

  • 52 Week Low

    $2.15

What are the historical returns of Aprea Therapeutics (APRE)?

  • 1 Month Returns

    -33.35%

  • 3 Months Returns

    -24.02%

  • 1 Year Returns

    -69.24%

  • 5 Years Returns

    -99.61%

Who is the Chief Executive Officer (CEO) of Aprea Therapeutics ?

Dr. Oren Gilad Ph.D. is the current Chief Executive Officer (CEO) of Aprea Therapeutics.